Tillkännagivande • Oct 02
MAV Beauty Brands Inc. acquired Sky Organics, LLC. MAV Beauty Brands Inc. acquired Sky Organics, LLC on October 1, 2024. The combined entity will operate under the MAV Beauty umbrella, maintaining headquarters in Toronto, Canada.
MAV Beauty Brands Inc. completed the acquisition of Sky Organics, LLC on October 1, 2024. Tillkännagivande • Nov 16
Nexus Capital Management LP entered into an asset purchase agreement to acquire Substantially all of the assets of MAV Beauty Brands Inc. Nexus Capital Management LP entered into an asset purchase agreement to acquire Substantially all of the assets of MAV Beauty Brands Inc. on November 14, 2023. MAV Beauty Brands has commenced voluntary proceedings under the Companies’ Creditors Arrangement Act (Canada) (“CCAA”) in the Ontario Superior Court of Justice (Commercial List) (the “Court”). Nexus has agreed to acquire substantially all of the assets
of the Company and its subsidiaries (the “Transaction”) for a purchase price significantly less than the current principal amount of the outstanding debt ($121.7 million). During the CCAA proceedings, it is expected that MAV Beauty Brands’ operations will continue uninterrupted in the ordinary course of business. In connection with the CCAA proceedings, the Court approved the appointment of Alvarez & Marsal Canada Inc. as monitor of the Company and its subsidiaries (the “Monitor”). Management will remain responsible for the day-to-day operations of the Company and, during the CCAA proceedings, the board of directors of the Company will remain in place, with the Company under the general oversight of the Monitor. It is anticipated that the trading of the Company’s common shares on the Toronto Stock Exchange (the “TSX”) will be halted and the TSX will place the Company under delisting review. A sale approval hearing is currently expected to take place on November 24, 2023 with the anticipated closing of the transaction to occur by the end of 2023, subject to the satisfaction or waiver of customary closing conditions and court approval. Tillkännagivande • Oct 01
MAV Beauty Brands Inc. Announces Board Changes MAV Beauty Brands Inc. announced that Scott Beattie has joined the Company's Board of Directors (the "Board") as an independent director, effective immediately. Mr. Beattie most recently served as non-executive Vice Chairman of the board of directors of Revlon Inc., and among several other board and executive experiences, previously served as Chairman and Chief Executive Officer of Elizabeth Arden, a global prestige beauty products company. Following Mr. Beattie's appointment, Jeffrey Barber and Kathy Mayor resigned from the Board. Reported Earnings • Aug 10
Second quarter 2023 earnings released: US$0.06 loss per share (vs US$0.007 profit in 2Q 2022) Second quarter 2023 results: US$0.06 loss per share (down from US$0.007 profit in 2Q 2022). Revenue: US$20.7m (down 19% from 2Q 2022). Net loss: US$2.22m (down US$2.48m from profit in 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 21 percentage points per year, which is a significant difference in performance. Tillkännagivande • Aug 09
MAV Beauty Brands Inc. to Report Q2, 2023 Results on Aug 09, 2023 MAV Beauty Brands Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 09, 2023 Buying Opportunity • Jul 21
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 44%. The fair value is estimated to be €0.086, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Meanwhile, the company became loss making. Tillkännagivande • May 25
MAV Beauty Brands Provides Board Update MAV Beauty Brands Inc. announced that Marc Anthony Venere has resigned from the Board of Directors, effective May 23, 2023. Mr. Venere is considering whether or not to participate in the Company's strategic review process and resigned from the Board of Directors to avoid any actual or perceived conflict in the event of his potential future participation in the strategic review process. There can be no assurances or guarantees that Mr. Venere will participate in the strategic review process or, if Mr. Venere does participate, the timing or terms of such participation. Given Mr. Venere's resignation, there are currently four director nominees proposed for election to the Board of Directors at the annual general meeting of shareholders of the Company to be held on June 13, 2023 (the "Meeting"), as further described in the Company's management information circular dated May 3, 2023 (the "Circular"). These remaining director nominees are Chris Elshaw, Jeffrey Barber, Stephen Smith and Kathy Mayor. The Company will not be replacing Mr. Venere with a new director nominee for election to the Board of Directors at the Meeting. Reported Earnings • May 12
First quarter 2023 earnings released: US$0.10 loss per share (vs US$0.017 loss in 1Q 2022) First quarter 2023 results: US$0.10 loss per share (further deteriorated from US$0.017 loss in 1Q 2022). Revenue: US$19.3m (down 8.9% from 1Q 2022). Net loss: US$3.87m (loss widened US$3.24m from 1Q 2022). Revenue is forecast to stay flat during the next 2 years compared to a 5.3% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 39 percentage points per year, which is a significant difference in performance. Buying Opportunity • Apr 03
Now 62% undervalued after recent price drop Over the last 90 days, the stock is down 11%. The fair value is estimated to be €0.35, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 8.1% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to decline by 9.6% in a year. Earnings is forecast to grow by 94% in the next year. Reported Earnings • Apr 02
Full year 2022 earnings released: US$4.24 loss per share (vs US$2.66 loss in FY 2021) Full year 2022 results: US$4.24 loss per share (further deteriorated from US$2.66 loss in FY 2021). Revenue: US$90.7m (down 15% from FY 2021). Net loss: US$155.8m (loss widened 60% from FY 2021). Revenue is forecast to grow 3.9% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance. Buying Opportunity • Mar 17
Now 27% undervalued The stock has been flat over the last 90 days. The fair value is estimated to be €0.63, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.5% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to decline by 0.6% in a year. Earnings is forecast to grow by 68% in the next year. Buying Opportunity • Feb 28
Now 26% undervalued Over the last 90 days, the stock is up 46%. The fair value is estimated to be €0.66, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.5% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to decline by 0.6% in a year. Earnings is forecast to grow by 68% in the next year. Board Change • Dec 20
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent Director Kathy Mayor was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Nov 18
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent Director Kathy Mayor was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 04
Third quarter 2022 earnings released: US$2.54 loss per share (vs US$2.81 loss in 3Q 2021) Third quarter 2022 results: US$2.54 loss per share (improved from US$2.81 loss in 3Q 2021). Revenue: US$22.0m (down 11% from 3Q 2021). Net loss: US$93.5m (loss narrowed 9.3% from 3Q 2021). Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 58 percentage points per year, which is a significant difference in performance. Board Change • Oct 04
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Independent Director Steve Smith was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 12
Second quarter 2022 earnings released: EPS: US$0.007 (vs US$0.11 in 2Q 2021) Second quarter 2022 results: EPS: US$0.007 (down from US$0.11 in 2Q 2021). Revenue: US$25.4m (down 13% from 2Q 2021). Net income: US$264.0k (down 94% from 2Q 2021). Profit margin: 1.0% (down from 14% in 2Q 2021). Over the next year, revenue is forecast to grow 12%, compared to a 8.0% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance. Board Change • Jul 20
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Independent Director Steve Smith was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • May 13
First quarter 2022 earnings released: US$0.017 loss per share (vs US$0.043 profit in 1Q 2021) First quarter 2022 results: US$0.017 loss per share (down from US$0.043 profit in 1Q 2021). Revenue: US$21.1m (down 26% from 1Q 2021). Net loss: US$632.0k (down 140% from profit in 1Q 2021). Over the next year, revenue is forecast to grow 8.1%, compared to a 12% growth forecast for the industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Independent Director Steve Smith was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Recent Insider Transactions • Nov 19
CEO & President recently bought €481k worth of stock On the 16th of November, Serge Jureidini bought around 500k shares on-market at roughly €0.96 per share. This was the largest purchase by an insider in the last 3 months. This was Serge's only on-market trade for the last 12 months. Reported Earnings • Nov 09
Third quarter 2021 earnings released: US$2.81 loss per share (vs US$0.097 profit in 3Q 2020) The company reported a poor third quarter result with weaker earnings, revenues and control over costs. Third quarter 2021 results: Revenue: US$24.7m (down 22% from 3Q 2020). Net loss: US$103.1m (down US$106.7m from profit in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has fallen by 44% per year, which means it is performing significantly worse than earnings. Board Change • Sep 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 1 highly experienced director. Independent Director Steve Smith was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Sep 02
Investor sentiment deteriorated over the past week After last week's 38% share price decline to €1.60, the stock trades at a trailing P/E ratio of 7.3x. Average forward P/E is 32x in the Personal Products industry in Europe. Total loss to shareholders of 81% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €2.18 per share. Reported Earnings • Aug 13
Second quarter 2021 earnings released: EPS US$0.11 (vs US$0.044 in 2Q 2020) The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: US$29.1m (down 1.8% from 2Q 2020). Net income: US$4.08m (up 154% from 2Q 2020). Profit margin: 14% (up from 5.4% in 2Q 2020). Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has fallen by 33% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Jul 15
Investor sentiment deteriorated over the past week After last week's 15% share price decline to US$2.62, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 33x in the Personal Products industry in Europe. Total returns to shareholders of 88% over the past year. Reported Earnings • May 11
First quarter 2021 earnings released: EPS US$0.043 (vs US$0.034 in 1Q 2020) The company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2021 results: Revenue: US$28.6m (down 8.7% from 1Q 2020). Net income: US$1.58m (up 28% from 1Q 2020). Profit margin: 5.5% (up from 3.9% in 1Q 2020). Executive Departure • May 11
Chief Financial Officer has left the company On the 10th of May, Judy Adam's tenure as Chief Financial Officer ended after 2.1 years in the role. We don't have any record of a personal shareholding under Judy's name. Judy is the only executive to leave the company over the last 12 months. Reported Earnings • Apr 02
Full year 2020 earnings released: EPS US$0.18 (vs US$0.11 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: US$116.5m (up 7.4% from FY 2019). Net income: US$6.51m (up 60% from FY 2019). Profit margin: 5.6% (up from 3.8% in FY 2019). Valuation Update With 7 Day Price Move • Feb 24
Investor sentiment deteriorated over the past week After last week's 17% share price decline to US$3.74, the stock is trading at a trailing P/E ratio of 33.1x, down from the previous P/E ratio of 39.8x. This compares to an average P/E of 21x in the Personal Products industry in Europe. Total returns to shareholders over the past year are 28%. Is New 90 Day High Low • Feb 10
New 90-day high: €4.60 The company is up 42% from its price of €3.24 on 11 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is down 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €10.11 per share. Valuation Update With 7 Day Price Move • Jan 21
Investor sentiment improved over the past week After last week's 15% share price gain to US$3.94, the stock is trading at a trailing P/E ratio of 35.2x, up from the previous P/E ratio of 30.5x. This compares to an average P/E of 23x in the Personal Products industry in Europe. Total returns to shareholders over the past year are 27%. Valuation Update With 7 Day Price Move • Jan 15
Investor sentiment improved over the past week After last week's 18% share price gain to US$3.70, the stock is trading at a trailing P/E ratio of 32.4x, up from the previous P/E ratio of 27.5x. This compares to an average P/E of 23x in the Personal Products industry in Europe. Total returns to shareholders over the past year are 8.2%. Valuation Update With 7 Day Price Move • Jan 14
Investor sentiment improved over the past week After last week's 15% share price gain to US$3.50, the stock is trading at a trailing P/E ratio of 31x, up from the previous P/E ratio of 26.9x. This compares to an average P/E of 22x in the Personal Products industry in Europe. Total returns to shareholders over the past year are 7.4%. Is New 90 Day High Low • Jan 13
New 90-day high: €3.48 The company is up 53% from its price of €2.28 on 15 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is down 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €9.51 per share. Reported Earnings • Nov 14
Third quarter 2020 earnings released: EPS US$0.097 The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: US$31.7m (up 12% from 3Q 2019). Net income: US$3.56m (up 21% from 3Q 2019). Profit margin: 11% (up from 10% in 3Q 2019). The increase in margin was driven by higher revenue. Analyst Estimate Surprise Post Earnings • Nov 14
Revenue beats expectations Revenue exceeded analyst estimates by 4.8%. Over the next year, revenue is forecast to grow 6.7%, compared to a 1.5% growth forecast for the Personal Products industry in Germany. Valuation Update With 7 Day Price Move • Nov 09
Market bids up stock over the past week After last week's 21% share price gain to US$2.96, the stock is trading at a trailing P/E ratio of 29.1x, up from the previous P/E ratio of 24x. This compares to an average P/E of 20x in the Personal Products industry in Europe. Total return to shareholders over the past year is a loss of 12%. Is New 90 Day High Low • Nov 07
New 90-day high: €2.54 The company is up 69% from its price of €1.50 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €6.61 per share. Is New 90 Day High Low • Oct 11
New 90-day high: €2.42 The company is up 73% from its price of €1.40 on 13 July 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €6.83 per share. 
